New schizophrenia drug tested for Long-Term safety in major trial

NCT ID NCT07114874

Recruiting now Disease control Sponsor: Neurocrine Biosciences Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 3 trial is testing the long-term safety of the drug NBI-1117568 in 600 adults with schizophrenia. Participants will receive the drug and be monitored for side effects over time. The study is open-label, meaning everyone knows they are getting the drug, and it focuses on safety rather than how well the drug works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: NBI-1117568
What this could lead to: If successful, this could provide a new long-term treatment option for schizophrenia with a favorable safety profile.
What could go wrong: This is an open-label study focused on safety, not efficacy. The drug may still have side effects or fail to control symptoms long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SCHIZOPHRENIA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Neurocrine Clincial Site
RECRUITING

Staten Island, New York, 10314, United States
Neurocrine Clinical Site
RECRUITING

Bryant, Arkansas, 72022, United States
Neurocrine Clinical Site
RECRUITING

Little Rock, Arkansas, 72211, United States
Neurocrine Clinical Site
RECRUITING

Cerritos, California, 90703, United States
Neurocrine Clinical Site
RECRUITING

Chino, California, 91710, United States
Neurocrine Clinical Site
RECRUITING

Culver City, California, 90230, United States
Neurocrine Clinical Site
RECRUITING

Garden Grove, California, 92845, United States
Neurocrine Clinical Site
RECRUITING

La Habra, California, 90631, United States
Neurocrine Clinical Site
RECRUITING

Lemon Grove, California, 91945, United States
Neurocrine Clinical Site
RECRUITING

Oceanside, California, 92056, United States
Neurocrine Clinical Site
RECRUITING

Pico Rivera, California, 90660, United States
Neurocrine Clinical Site
RECRUITING

Riverside, California, 92506, United States
Neurocrine Clinical Site
RECRUITING

San Diego, California, 92123, United States
Neurocrine Clinical Site
RECRUITING

Sherman, California, 91403, United States
Neurocrine Clinical Site
RECRUITING

Torrance, California, 90504, United States
Neurocrine Clinical Site
RECRUITING

West Hills, California, 91307, United States
Neurocrine Clinical Site
RECRUITING

Atlantis, Florida, 30328, United States
Neurocrine Clinical Site
RECRUITING

Aventura, Florida, 33108, United States
Neurocrine Clinical Site
RECRUITING

Doral, Florida, 33178, United States
Neurocrine Clinical Site
RECRUITING

Hollywood, Florida, 33024, United States
Neurocrine Clinical Site
RECRUITING

Maitland, Florida, 32751, United States
Neurocrine Clinical Site
RECRUITING

Miami, Florida, 33122, United States
Neurocrine Clinical Site
RECRUITING

Miami, Florida, 33155, United States
Neurocrine Clinical Site
RECRUITING

Miami Lakes, Florida, 33016, United States
Neurocrine Clinical Site
RECRUITING

Tampa, Florida, 33629, United States
Neurocrine Clinical Site
RECRUITING

West Palm Beach, Florida, 33407, United States
Neurocrine Clinical Site
RECRUITING

Atlanta, Georgia, 30328, United States
Neurocrine Clinical Site
RECRUITING

Atlanta, Georgia, 30331, United States
Neurocrine Clinical Site
RECRUITING

Decatur, Georgia, 30030, United States
Neurocrine Clinical Site
RECRUITING

Chicago, Illinois, 60640, United States
Neurocrine Clinical Site
RECRUITING

Gaithersburg, Maryland, 20877, United States
Neurocrine Clinical Site
RECRUITING

Boston, Massachusetts, 02116, United States
Neurocrine Clinical Site
RECRUITING

Watertown, Massachusetts, 02472, United States
Neurocrine Clinical Site
RECRUITING

Flowood, Mississippi, 39232, United States
Neurocrine Clinical Site
RECRUITING

St Louis, Missouri, 63141, United States
Neurocrine Clinical Site
RECRUITING

Marlton, New Jersey, 08053, United States
Neurocrine Clinical Site
RECRUITING

Cedarhurst, New York, 11516, United States
Neurocrine Clinical Site
RECRUITING

New York, New York, 10029, United States
Neurocrine Clinical Site
RECRUITING

New York, New York, 10036, United States
Neurocrine Clinical Site
RECRUITING

Philadelphia, Pennsylvania, 19104, United States
Neurocrine Clinical Site
RECRUITING

Austin, Texas, 78754, United States
Neurocrine Clinical Site
RECRUITING

DeSoto, Texas, 75115, United States
Neurocrine Clinical Site
RECRUITING

Houston, Texas, 77043, United States
Neurocrine Clinical Site
RECRUITING

Orem, Utah, 84058, United States
Neurocrine Clinical Site
RECRUITING

Bellevue, Washington, 98007, United States
Neurocrine Clinical Site
WITHDRAWN

Veliko Tarnovo, 5047, Bulgaria
Neurocrine Clinical Site
RECRUITING

Vratsa, 5047, Bulgaria
Neurocrine Clinical Site
RECRUITING

Brasov, 500123, Romania
Neurocrine Clinical Site
RECRUITING

Bucharest, 41914, Romania
Neurocrine Clinical Site
RECRUITING

Sânpetru, 507190, Romania
Neurocrine Clinical Site
RECRUITING

Belgrade, 11000, Serbia
Neurocrine Clinical Site
RECRUITING

Gornja Toponica, 18202, Serbia
Neurocrine Clinical Site
RECRUITING

Kragujevac, 34000, Serbia
Neurocrine Clinical Sites
RECRUITING

Peachtree Corners, Georgia, 30071, United States
Neurocrine Clinical Sites
RECRUITING

The Bronx, New York, 10461, United States
Neurocrine Clinical Sites
RECRUITING

North Canton, Ohio, 44720, United States
Neurocrine Clinical Sites
RECRUITING

Orem, Utah, 84058, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.